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Objectives: Fibromyalgia (FM) is a chronic condition characterized by widespread 
  musculoskeletal pain, fatigue, depression, and hypocortisolism. To date, published studies have 
not investigated the effects of yoga on cortisol in FM. This pilot study used a time series design 
to evaluate pain, psychological variables, mindfulness, and cortisol in women with FM before 
and after a yoga intervention.
Methods: Participants (n = 22) were recruited from the community to participate in a 
75   minute yoga class twice weekly for 8 weeks. Questionnaires concerning pain (intensity, 
unpleasantness, quality, sum of local areas of pain, catastrophizing, acceptance, disability), 
anxiety, depression, and mindfulness were administered pre-, mid- and post-intervention. 
Salivary cortisol samples were collected three times a day for each of two days, pre- and 
post-intervention.
Results: Repeated measures analysis of variance (ANOVA) revealed that mean ± standard 
deviation (SD) scores improved significantly (p , 0.05) from pre- to post-intervention for 
continuous pain (pre: 5.18 ± 1.72; post: 4.44 ± 2.03), pain catastrophizing (pre: 25.33 ± 14.77; 
post: 20.40 ± 17.01), pain acceptance (pre: 60.47 ± 23.43; post: 65.50 ± 22.93), and mindfulness 
(pre: 120.21 ± 21.80; post: 130.63 ± 20.82). Intention-to-treat analysis showed that median AUC 
for post-intervention cortisol (263.69) was significantly higher (p , 0.05) than median AUC 
for pre-intervention levels (189.46). Mediation analysis revealed that mid-intervention mindful-
ness scores significantly (p , 0.05) mediated the relationship between pre- and post-intervention 
pain catastrophizing scores.
Discussion: The results suggest that a yoga intervention may reduce pain and catastrophizing, 
increase acceptance and mindfulness, and alter total cortisol levels in women with FM. 
The changes in mindfulness and cortisol levels may provide preliminary evidence for mecha-
nisms of a yoga program for women with FM. Future studies should use an RCT design with 
a larger sample size.
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Introduction
Fibromyalgia (FM) is a poorly understood condition that is characterized by widespread 
musculoskeletal pain and presents with other symptoms such as fatigue, cognitive 
dysfunction, sleep disturbances, anxiety, depression, gastrointestinal discomfort and 
stiffness.1 Recent proposed changes to the American College of Rheumatology (ACR) 
formal diagnostic criteria for FM include implementation of the widespread pain index 
(WPI) and symptom severity scale (SS), to supplement the previous gold standard of Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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a tender point count, along with widespread pain for at least 
3 months in at least 3 of the 4 quadrants of the body.2
Female gender, older age, low level of education, low 
socio-economic status, and divorce have been associated 
with FM.3 Psychological distress is a major risk factor for 
long term complaints4 and comorbidity with anxiety and 
depression is high,3 with rates of 13%–64% and 20%–80%, 
respectively.5 Moreover, FM patients display generalized 
hypervigilance,6 characterized by a greater sensitivity to 
external stimuli in various modalities. Pain catastrophizing 
and low pain-self efficacy are other psychological factors 
that prevent healthy adjustment to FM7 and contribute to 
disability,8 pain, depression and quality of well being.9 
Although the neurophysiological underpinnings of this dis-
order have yet to be elucidated, there is evidence that central 
sensitization is largely implicated in the extensive and endur-
ing pain and that FM is accompanied by altered hypothalamic 
pituitary adrenal (HPA) axis and autonomic nervous system 
(ANS) functioning.3
Cortisol is a steroid hormone that is produced and released 
by the adrenal gland, and functions as a component of the 
hypothalamic-pituitary-adrenal (HPA) axis in response to 
stress or low blood sugar. Healthy HPA axis functioning, as 
measured by cortisol secretion, entails higher cortisol levels 
upon waking, a peak approximately 30–40 minutes post-
waking (the cortisol awakening response [CAR]) and a 
decline over the course of the day, when levels reach a trough 
prior to sleep onset.10 Healthy functioning also involves HPA 
resilience, which refers to the ability of the HPA system to 
recover or rebound from stress. The literature on HPA func-
tioning and cortisol levels in FM patients is equivocal.11 
A host of variables complicates an accurate portrayal of HPA 
function, but variations in the methods used to collect cortisol 
samples, such as time of cortisol measurement (morning, 
afternoon, evening), number of measurements per day (1–8, 
or continuous readings), and source (salivary, plasma, serum 
or urinary) of cortisol, make it particularly difficult to derive 
a clear picture of HPA activity in FM patients.12
Notwithstanding the variability in cortisol sampling 
procedures and findings, it is accepted that there is a dys-
regulation of HPA functioning in patients with FM,11 result-
ing in alterations in levels of cortisol, corticotropin-releasing 
hormone, growth hormone and thyroid hormones, which may 
have secondary effects on pain, fatigue, immune function, 
mood and sleep.3 Recent research indicates that FM patients 
exhibit hypocortisolism, particularly as an attenuated CAR.13 
Hypocortisolism is characterized by a blunted presentation 
of cortisol secretion, compromised HPA resilience and a triad 
of pain, fatigue and stress sensitivity.14 In support of this idea, 
women with FM have lower urinary15 and salivary cortisol 
levels16 than healthy controls, and less diurnal variability in 
comparison to individuals with rheumatoid arthritis.17 In addi-
tion, core features of FM, such as fatigue, pain, and psycho-
logical stress, have been associated with lower morning 
cortisol levels and blunted diurnal slopes.18–20 HPA axis 
dysfunction has also been associated with psychological 
dysfunction, such as depression, and stress but not with pain 
in patients with FM,12 indicating that the relationship between 
HPA function, pain and psychological distress in FM needs 
further examination.
Treatments for FM are general in nature and include the 
use of both pharmacological and non-pharmacological 
symptom management. Exercise is widely used as a treatment 
option and guidelines have been suggested for optimal 
results: minimize micromuscle trauma, minimize central 
sensitization, emphasize low-intensity exercise, individualize 
exercise, and maximize self-efficacy.21 Although research 
findings concerning isometric exercise and pain levels in FM 
are mixed, results from a randomized controlled trial indicate 
that cortisol levels in individuals with fibromyalgia do not 
differ from healthy controls when performing static muscular 
work and isometric contraction.22–24 Yoga has been used as 
a treatment for a variety of chronic conditions in which pain 
is a predominant feature.25 To date, there are only two 
  published studies of yoga for the treatment of FM.26,27 
  Improvements were seen on measures of pain, fatigue, mood, 
pain catastrophizing, acceptance and coping in FM patients 
when compared to waitlist controls, and in pain scores when 
compared to a yoga plus touch condition.27 Findings from 
these studies suggest that yoga improves pain, fatigue and 
psychological variables in an FM population. Further inves-
tigation is needed to examine how yoga affects other psy-
chological domains and functional capacity, such as 
mindfulness and pain disability.26
Mindfulness as a construct has garnered recognition for 
its therapeutic gains in a variety of pain related conditions. It 
is rooted in Buddhist and contemplative philosophies and is 
characterized by paying total attention to the present moment 
with a non-judgmental awareness of inner and outer 
  experiences.28 Benefits of mindfulness practices for FM 
include the reduction of depressive symptoms mid- and post-
treatment,29 decreases in sympathetic autonomic arousal after 
meditation,30 and reduced heat-induced pain intensity and 
unpleasantness ratings in response to slowed breathing prac-
tices.31 Since yoga encompasses elements of mindfulness and 
includes breathing techniques, it is possible that the benefits Journal of Pain Research 2011:4
Participants screened for eligibility
N = 57
Attended information session
n = 24
Completed the intervention
n = 19
Attended the first class and
provided saliva
samples/demographic
information/questionnaire data
n = 22
Dropped out, n = 2
• New job, n = 1
• Declined, n = 1
Dropped out, n = 3
• Medical reason, n = 1
• Relocated, n = 1
• Declined, n = 1
Excluded, n = 33
• Did not meet exclusion criteria, n = 8
• Could not provide doctor’s note, n = 4
• Time schedule conflict, n = 9
• Declined to participate, n = 8
• No persisting FM symptoms, n = 1
• Replied after study had started, n = 3
Figure 1 Participant flow through the course of the study.
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of yoga may be, in part, due to the evolving   perspective and 
awareness that result from mindfulness.
Yoga may also exert its effects through physiological 
mechanisms, as it impacts the hypothalamic-pituitary-adrenal 
(HPA) axis. Specifically, morning levels of cortisol increased 
in both depressed patients who participated in a yoga inter-
vention and in yoga practitioners when compared to 
controls,32,33 and cortisol levels decreased in undergraduate 
students after one yoga class,34 in yoga teachers over a one-
day yoga intensive,35 in self-referred women after one yoga 
class,36 and in detoxifying youth after a yogic breathing 
program.37 Other studies did not report changes in cortisol 
post-yoga intervention.38–40 Taken together, the findings 
regarding the effects of yoga on HPA functioning are con-
troversial and the use of standardized protocols for cortisol 
collection in research involving yoga interventions would be 
beneficial.
Although many studies of HPA functioning have been 
conducted in FM patients, the effects of a yoga intervention 
on cortisol levels in patients with FM have not yet been 
evaluated. Moreover, the effects of yoga on physiological, 
psychological, functional and pain variables have yet to be 
evaluated in a single study of patients with FM. Since yoga 
has been shown to alleviate many FM symptoms, such as 
pain and psychological functioning, and to improve HPA 
functioning in other populations, it is possible that yoga may 
improve HPA functioning, as measured by increased cortisol 
levels. The objectives of this pilot study were to evaluate the 
effects of an eight-week Hatha yoga intervention on measures 
of (1) pain (intensity, unpleasantness, quality, sum of local 
areas, pain catastrophizing, pain acceptance, pain disability), 
(2) general psychosocial functioning (anxiety, depression), 
(3) mindfulness, and (4) cortisol in a sample of patients with 
FM. It was hypothesized that the yoga program would result 
in improvements in pain and pain-related variables, psycho-
logical functioning, mindfulness, and increases of cortisol 
levels, greater diurnal variability, and a greater CAR.
Materials and methods
subjects
Due to the higher prevalence of FM in women than men,3 
and the likelihood of disproportionate numbers of men and 
women in the yoga classes, only women were included in 
this study. The main inclusion criterion was written docu-
mentation of a diagnosis of FM by a physician. Exclusion 
criteria were: males with FM; a current yoga practice (or a 
recent practice in the past six months); self-reported or diag-
nosed bipolar, psychotic, or personality disorders; change in 
any medication in the month prior to the commencement of 
the saliva collection and yoga program; a habit of smoking 
more than 15 cigarettes a day; and currently pregnant or 
breastfeeding. Women with FM were recruited through 
public advertisements (postings in locations including gov-
ernment and school community centers, book stores, health 
food stores), support groups, health centers, and pain clinics 
in Toronto. Figure 1 shows the flow of participants through 
the study. Between April 2010 and May 2010, 57 women 
were screened, 24 of whom were eligible and available for 
the yoga classes and 19 completed the yoga program. The 
yoga program ran from June 16th to August 20th, 2010. The 
research protocol was reviewed and approved by the Human 
Participants Review Committee at York University prior to 
the start of the study.
Procedure
As depicted in Figure 2, the program consisted of several 
components: an information session; pre- and post-program 
saliva collection; yoga classes; a follow-up session; and 
administration of self-report questionnaires. Questionnaires 
were administered at three time (T) points: pre- (T1), mid- 
(T2), and post- (T3) intervention.Journal of Pain Research 2011:4
Information
session
Time
(days)
Saliva
collection
Yoga program
(2 classes/week for 8 weeks)
Saliva
collection
Follow-up
session
T3
Questionnaires
T2
Questionnaires
T1
Questionnaires
−7 −1 −2 02 65 65 75 86 0
Figure 2 Order and time sequence of data collection. The information session was held seven days before the yoga program began. saliva samples for cortisol analysis were 
collected on the two days before and the two days after the yoga program, for a total of four days. The yoga program ran for 8 weeks (2 classes/week) and the follow-up 
session took place two days after the final day of saliva collection. Questionnaires concerning pain and related variables, psychological factors and mindfulness were evaluated 
at three time points (T1, T2 and T3).
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Recruitment and information session
Prospective participants who contacted the study coordinator 
were interviewed over the telephone using a script to deter-
mine eligibility. Those who met the eligibility criteria were 
emailed a general information letter about the program, the 
informed consent form, and a document outlining ways to 
decrease and prevent muscle soreness or tightness. The infor-
mation letter outlined what was to be expected in terms of 
attendance, commitment, pacing, initial increases in pain due 
to overexertion, and how to handle flare-ups during the yoga 
program. Participants brought the consent form and a doctor’s 
note confirming a diagnosis of FM to the information session, 
where they were provided with saliva collection kits and 
were given detailed instructions for taking samples. All par-
ticipants were educated in the proper procedures for saliva 
collection, were given general instructions concerning the 
yoga program and were provided the opportunity to ask 
questions and discuss concerns.
saliva collection kits
Saliva collection kits consisted of a booklet titled “Saliva 
Sample Collection and Information Instructions” with edu-
cational information about cortisol, labeled diagrams and 
explanations of the saliva collection equipment, step by step 
instructions for taking samples and recording information.41 
Saliva sampling equipment (Salimetrics LLC, State College, 
PA) consisted of a small cotton swab, housed inside a cen-
trifugation tube, in turn housed in a holding tube. All holding 
tubes were pre-labeled according to participant number, day 
(1, 2), and sample (S1, S2, S3) number using freeze resistant 
labels provided by Salimetrics. Participants were provided 
with freezer bags labeled for each day of collection. The kits 
also contained a diary to record the date and time when each 
sample was taken, as well as questions about consumption 
of food, alcohol, caffeinated beverages, and drugs, and 
  exercise activities around the time of sampling. Lastly, the 
kits contained a question and answer sheet relevant to com-
monly asked questions about saliva collection.
Pre- and post-program salivary cortisol 
collection
Participants took three pre-intervention samples on each of 
the two consecutive days prior to the start of the study, and 
another three samples on each of the two consecutive days 
beginning the day after the final yoga class, according to a 
two day sampling technique.42 The first sample (S1) was 
taken promptly upon awaking in the morning, the second 
sample (S2) was taken 30 minutes later, before brushing 
teeth, consuming food or beverages, or exercising, and the 
final sample (S3) was taken at night right before going to 
sleep. Participants were instructed not to exercise, consume 
drugs, alcohol, beverages or food within the hour before S3. 
All participants were called the night before the first day 
(pre- and post-intervention) of saliva sample collection to 
review the saliva sampling protocol and to answer any 
questions.
When taking a sample, participants were instructed to 
place a cotton swab under the tongue for at least 60 seconds, 
deposit the cotton swab into the centrifugation tube within 
the holding tube and store the entire sample in a freezer. 
Participants brought the pre- and post-intervention frozen 
samples to the studio on the first day of the yoga program 
and on the day of the scheduled follow-up session, respec-
tively. The samples were transferred to a secure freezer until 
the end of the program, when both sets of samples were 
couriered to Salimetrics for cortisol immunoassay.
Yoga classes
Participants attended two 75-minute Hatha yoga classes each 
week for 8 weeks at Vidya Institute in Toronto. Classes were Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
193
Yoga intervention for women with fibromyalgia
taught by a certified Yoga Alliance (Toronto, ON) instructor 
(KC) with 200 hours training. Hatha yoga is a mind-body 
practice that was developed in 15th century India, in which 
physical yoga postures were practiced to prepare the mind 
for meditation. Theoretically, the term Hatha is composed 
of the Sanskrit terms “Ha” and “Tha”, which refer to the sun, 
or heating and activating properties, and to the moon, or 
cooling or calming properties, respectively. By balancing 
these opposing qualities, physical and mental health are 
fostered and the development of self-awareness and mind-
body unity are cultivated.43 Hatha yoga is an appropriate form 
of yoga for women with FM since it is gentle, can be easily 
modified to accommodate individual medical conditions and 
difficulties with mobility. The classes consisted of traditional, 
modified, and restorative yoga postures (asana), breathing 
exercises (pranayama), a brief meditation (dhyana),25 
  intention setting, mindfulness exercises and an introduction 
to the eight limbs of yoga. Participants were neither encour-
aged nor discouraged to practice asana at home between 
classes, and measures of home practice were not taken.
This program is similar in format to the Yoga as Awareness 
program developed by Carsen et al26 for women with FM, but 
differed in that short yoga philosophy teachings were given 
instead of dyadic presentations and that there was no group 
discussion in the present study. Teaching aspects of yoga 
philosophy, such as ahimsa (non-violence), aparigraha (non-
grasping) and niyamas (guidance for one’s relationships to the 
self) provided direction to participants for practicing the pos-
tures and breathing techniques, as recommended for chronic 
pain patients.44 Special care was taken in the formulation of 
instructions for practicing the postures so that they were tai-
lored to individuals with FM, specific cues were given to 
provide participants with techniques for monitoring how to 
safely practice the postures when in pain and considerable 
instruction was given regarding the nature of a non-  judgmental, 
compassionate, and accepting approach to practice.
All yoga classes began with philosophy teachings con-
cerning the eight limbs of yoga, which are ethical consider-
ations and guidelines to living a meaningful and purposeful 
life. These teachings were then practically applied to the 
physical yoga postures, as well as to a physical practice where 
pain is a predominant sensory experience. Modifications and 
variations in postures and purposeful sequencing were used 
to accommodate the pathophysiology and functional changes 
associated with FM.26 Slow transitions between asanas were 
used to address autonomic nervous system (ANS) dysregula-
tion and restorative postures were interwoven throughout the 
class to calm the sympathetic nervous system. Low impact 
and intensity postures were used to minimize micromuscle 
trauma, and modified asanas (eg, sun salutation at the wall, 
variations of sitting postures) and props (blocks, straps and 
bolsters) were used to minimize musculoskeletal pain in the 
knees, back, hips, and wrists. Classes ended with corpse pose 
(savasana), which was accompanied by body scans and 
visualization practices, in order to help participants embrace 
relaxation, embody presence, and to serve as a focus for the 
mind, liberating it from attending to pain.44
Follow-up session
Three days after the final yoga class, participants attended a 
follow-up session at the studio, where they returned the 
frozen post-intervention saliva samples, completed the final 
set of questionnaires, and debriefed about their experiences. 
In specific cases where participants could not attend the 
follow-up  session,  individual  meeting  times  were 
organized.
Measures
All participants were given a package of questionnaires at 
three time points to evaluate pain, mood, psychological 
functioning and mindfulness. The first set of questionnaires 
(T1) was completed at the yoga studio 45 minutes before the 
first class along with demographic and clinical information 
concerning occupation, education, ethnicity, medical or 
psychiatric illness, medication use and socioeconomic status. 
The second set (T2) was completed by participants at home 
or at the yoga studio before the ninth class, and the third set 
(T3) was filled out at the follow-up session. The study coor-
dinator (KC) was available to answer any questions and guide 
participants when completing the forms. Each questionnaire 
package consisted of the following measures.
McGill Pain Questionnaire short-form 2  
(MPQ-SF-2)
The MPQ-SF-245 is a multi-dimensional measure of pain that 
consists of 22 pain descriptors. Participants rate each descrip-
tor on an 11-point scale ranging from 0 (“none”) to 10 (“worst 
possible”). Subscale scores are computed by calculating mean 
ratings for the following subscales: (1) continuous pain, 
(2) intermittent pain, (3) neuropathic pain, and (4) affective 
descriptors. Total score is the mean of the four subscale scores. 
The MPQ-SF-2 has very good to excellent psychometric 
properties, including adequate to high internal consistency 
reliability estimates for the four subscales (0.73–0.87) and 
the total score (0.91–0.95), good construct validity, and sen-
sitivity to change in response to pharmacotherapy.45Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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numeric Rating scale (nRs) for pain  
intensity (i) and unpleasantness (U)
The NRS46 provided a global measure of pain intensity and 
pain unpleasantness. Participants were instructed to rate 
the general level of pain intensity and pain unpleasantness 
experienced over the past week on an 11-point scale with 
endpoints of 0 (“no pain”) and 10 (“the most intense pain 
sensation imaginable”) for NRS-I, and 0 (“not unpleasant”) 
and 10 (“the most unpleasant sensation imaginable”) 
for NRS-U. NRSs for pain have good construct validity,46 
show significant, positive correlations with other mea-
sures of pain, and are sensitive to change in response to 
treatment.46
sum of Local Areas of Pain (sLAP)
The SLAP47 consists of diagrams of the human body depict-
ing both the front and the back view divided into 20 areas, 
18 of which include standard FM tender points with an 
additional two areas on the abdomen. The SLAP also consists 
of many of the same areas as the WPI,2 which measures 19 
body regions for pain, although the two measures divide body 
regions differently. For instance, the SLAP measures the 
front and back of each arm as separate regions, while the 
WPI measures the upper and lower portions of each arm. 
Participants are instructed to circle areas in which they have 
been experiencing pain over the past week. The SLAP was 
selected for this study since (1) the practicality, accuracy and 
reliability of using tender points to determine pain intensity 
in FM patients has been questioned,2 (2) tender point count 
requires specialized training, and (3) the SLAP has been 
shown to be a better clinical predictor of pain than tender 
point count in FM patients.47
Pain Catastrophizing scale (PCs)
The PCS48 is a 13-item self-report questionnaire that mea-
sures catastrophic thinking in relation to experienced or 
anticipated pain. Participants are asked to read each item and 
indicate the extent to which they experience certain thoughts 
and feelings when experiencing pain by selecting a number 
from 0 (“not at all”) to 4 (“all the time”). Scores range from 
0–52, with higher scores reflecting higher levels of pain 
catastrophizing. The PCS yields a total score and three sub-
scale scores assessing rumination (focus on pain sensations), 
magnification (exaggerating the threat value of pain sensa-
tions) and helplessness (perceiving oneself as unable to cope 
with pain symptoms). The PCS has high internal consistency 
(  coefficient alphas: total PCS = 0.87, rumination = 0.87, 
magnification = 0.66, and helplessness = 0.78).
Pain Disability index (PDi)
The PDI49 is a self-report questionnaire that measures the 
extent to which pain interferes with seven daily activities 
and life domains. Each domain is rated on an 11-point scale 
ranging from 0 (“no disability”) to 10 (“total disability”). 
The total score ranges from 0 to 70, with higher scores indi-
cating more pain disability. The PDI has high internal con-
sistency (α = 0.86), modest test-re-test reliability (α = 0.44), 
and good concurrent validity based on significant correlations 
with objective measures of pain related disability.49
hospital Anxiety and Depression scale (hADs)
The HADS50 is a 14-item self-report questionnaire that mea-
sures symptoms of anxiety (7 items) and depression (7 items). 
For each item, participants are asked to select one from 
among four possible choices (scored from 0 to 3) that best 
describes how they have been feeling over the past week. The 
HADS yields an anxiety (HADS-A) and a depression 
(HADS-D) subscale score, each with a maximum total score 
of 21. Internal consistency is high for both the HADS-A 
(α = 0.83) and HADS-D (α = 0.82) subscales.51 Concurrent 
validity of the HADS is very good, as measured by correla-
tion coefficients of between 0.62 and 0.73 for the HADS-D 
with various well-validated depression scales and correlation 
coefficients of between 0.49 and 0.81 for the HADS-A with 
various well-validated anxiety measures.51
Five Facet Mindfulness Questionnaire (FFMQ)
The FFMQ52 is a 39-item self-report questionnaire that mea-
sures levels of mindfulness according to five facets: observ-
ing, describing, acting with awareness, non-judging of inner 
experience, and non-reactivity to inner experience. Partici-
pants respond to each item by selecting the number that is 
“most generally true” of his/her experience, on a scale of 1 
(“never or rarely true”) to 5 (“very often or always true”). 
Total scores range from 0 to 195. Higher scores indicate 
greater levels of mindfulness. Each subscale of the FFMQ 
describes different areas of mindfulness and is correlated 
with different aspects of psychological functioning. 
For instance, the describing facet is most positively correlated 
with emotional intelligence and negatively correlated with 
alexithymia, which is characterized by difficulty identifying 
physical symptoms as somatic representations of emotions, 
while the non-reactivity facet is most positively correlated 
with self-compassion, and the observing facet with 
  openness.52 The FFMQ is based on a factor analytic study of 
five independently developed mindfulness questionnaires, 
with good internal consistency52 and construct validity.53Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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Chronic Pain Acceptance Questionnaire (CPAQ)
The CPAQ54 is a 20-item questionnaire that measures how 
participants react and adapt to living with chronic pain. 
  Participants are asked to respond to “how true” each item is 
by selecting a number from 0 (“never true”) to 6 (“always 
true”). The items load on a two-factor model including activity 
engagement and pain willingness (recognition that pain avoid-
ance is not a helpful way to cope).54 The CPAQ has adequate 
internal consistency (Cronbach’s α: total = 0.78, activity 
engagement = 0.78, pain willingness = 0.85). Both factors 
significantly predict pain-related disability and distress.54
salivary cortisol measurement
All saliva samples were assayed for cortisol in duplicate using 
a highly sensitive enzyme immunoassay (Salimetrics, State 
College, PA). The test used 25 µL of saliva per determination, 
has a lower limit of sensitivity of 0.003 µg/dL, standard curve 
range from 0.012 µg/dL to 3.0 µg/dL, an average intra-assay 
coefficient of variation of 3.5% and an average inter-assay 
coefficient of variation of 5.1%. Method accuracy, determined 
by spike and recovery, averaged 100.8%, and linearity, deter-
mined by serial dilution, averaged 91.7%. Values from 
matched serum and saliva samples show the expected strong 
linear relationship, r (47) = 0.91, p , 0.0001. A random 
selection of 10% of the samples was analyzed twice in order 
to determine reliability of the assay.
Data preparation and analysis
After examining the salivary cortisol levels (µg/dL) for nor-
mality and outliers (described below) the data were averaged 
across the two sampling days to produce one value for each 
participant at each of the three sampling points, for both pre- 
and post-intervention, yielding six values for each participant. 
Based on previous research, three different cortisol measures 
were calculated: (1) total area under the curve (AUC),55 which 
provides information about total cortisol output, (2) CAR, 
calculated as the difference between S2 and S1,19 and (3) 
diurnal change, calculated as the difference between 
S1 and S3.56 The AUC was calculated separately for each of 
the four collection days, then the two pre-  intervention AUCs 
were averaged to produce one pre-  intervention AUC value 
for each participant and similarly, the two post-intervention 
AUCs were averaged to produce one post-  intervention AUC 
value for each participant.
Statistical analysis was performed with SPSS (Somers, 
NY) version 19.0. Demographic, clinical and diary-related 
variables were analyzed using the descriptive and the explore 
functions. The raw data was explored for skew and was 
analyzed using the Shapiro–Wilk test for normality and 
Levene’s test for homogeneity of variance. Pre- and post- 
values of the AUC, the CAR and diurnal change were com-
pared using paired samples t-tests or Wilcoxon signed-rank 
tests, depending on violations of assumptions associated with 
the former test.
All self-report measures were assessed for normality 
using the Shapiro–Wilk test. Self-report data were analyzed 
using grouped repeated measures MANOVAs, which were 
followed by one-way repeated measures ANOVAs (T1, T2, 
T3) and LSD post hoc analysis in the presence of a significant 
main effect of time.57 Sphericity was evaluated using Bartlett’s 
test and in all cases of violation, Huynh–Feldt adjustments 
were used.
Simple mediation analysis was conducted using a boot-
strapping approach (2,000 resamples), as recommended for 
small sample sizes,58 to evaluate the mediating effect of total 
FFMQ scores at T2 on the relationship between PCS scores 
at T1 and T3.
Data are reported as mean ± SD unless otherwise 
stated.
Results
Demographic and clinical variables
The characteristics of the sample are summarized in Table 1. 
The mean age was 47.4 ± 13.7 years (range: 17–71 years); 
height was 163.6 ± 8.43 cm (range: 142.2–177.8 cm) and 
weight was 70.98 kg ± 18.89 (range: 53.5–132.9 kg). 
  Participants had been diagnosed with FM for an average of 
13.2 ± 8.6 years (range: 1–27 years). Participant use of vari-
ous pain treatments (pharmacological, natural health prod-
ucts, physical approaches, psychological approaches and 
medical interventions) are displayed in Table 2. The 
mean ± SD number of yoga classes attended was 12.9 ± 2.02 
(out of 15) and 86.36% of the participants completed the 
yoga program.
Treatment results
Repeated measures analysis for pain and related 
variables, psychological factors and mindfulness
Three repeated measures MANOVAs were conducted for 
groups of similar variables: (1) pain variables (NRS-I, NRS-U, 
MPQ-SF-2, SLAP), (2) pain-related variables (PCS, CPAQ, 
PDI) and (3) mood and mindfulness variables (HADS-D, 
HADS-A, FFMQ), to determine changes in those sets of 
dependent variables over time. A significant multivariate time 
effect was found for pain-related and mood and   mindfulness 
variables, V = 0.42, F (6.0, 66.0) = 2.92, p , 0.05, and V = 0.36,   Journal of Pain Research 2011:4
Table 1 Demographic and clinical variables at baseline (n = 22)
Demographic N (%)/M(SD)
Age 47.4 (13.73)
height 163.58 (8.43)
Weight (kg) 70.98 (18.89)
Body mass index (BMi) 26.48 (6.27)
Years since diagnosis 13.16 (8.55)
Race/ethnicity
  African Canadian 1 (4.5%)
  south Asian 1 (4.5%)
  east Asian 1 (4.5%)
  Middle eastern/north 1 (4.5%)
  Caucasian 16 (72.7%)
  hispanic 1 (4.5%)
  West indian 1 (4.5%)
socioeconomic class
  high 0 (0.0%)
  Middle-high 1 (4.5%)
  Middle 13 (59.1%)
  Middle-low 2 (9.1%)
  Low 5 (22.7%)
employed 8 (36.4%)
Level of education
  grade-school 1 (4.5%)
  high-school 3 (13.6%)
  University/college 14 (63.6%)
  Post-graduate school 4 (18.2%)   
smokes cigarettes 4 (18.2%)
Major life event in past year 11 (50.0%)
Presence of other ongoing 16 (72.6%)
pain problems
Fibromyalgia pain frequency
  Daily 15 (68.2%)
  Weekly 4 (18.2%)
  Monthly 0
  Other 3 (13.6%)
Average pain intensity
  Mild 4 (18.2%)
  Moderate 9 (40.9%)
  severe 9 (40.9%)
Table 2 Pain medications and treatments previously or currently 
used (n = 22)
Pain medication and treatments N (%)
Pharmacological medications 18 (81.8)
  Opioid based medications 9 (40.9)
  Non-steroidal anti-inflammatory drugs 10 (45.5)
  Anti-convulsant drugs 4 (18.2)
  Acetaminophen 8 (36.4)
  Antidepressants 3 (13.6)
natural health products 18 (81.8)
  supplements and vitamins, marijuana,
  herbs, homeopathy, essential oils, etc
Physical approaches 20 (90.9)
  Massage, acupuncture, Tai Chi,
  physiotherapy, chiropracty,
  craniosacral treatment, etc
Psychological approaches 17 (77.3)
  Meditation, breathing exercises,
  psychotherapy, distraction, relaxation,
  religion, hypnosis, etc
Medical interventions 6 (27.3)
  Cortisone, anesthetic injections
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F (6.0, 66.0) = 2.44, p , 0.05, respectively, but not for the 
pain variables, V = 0.17, F (8.0, 64.0) = 0.75, p . 0.05. Uni-
variate ANOVAs were conducted for all measures, including 
the pain variables, as it was possible that the small sample 
size may have contributed to the lack of significance in this 
grouping.
Table 3 shows the means and SDs for each measure across 
the three time points, as well as significant p values. Huynh-
Feldt adjusted F-tests revealed a significant main effect of 
time for PCS-total, F (2.0, 34.0) = 3.46, p , 0.05, ηp
2 = 0.17, 
PCS-helplessness, F (1.9, 31.8) = 3.77, p , 0.05, ηp
2 = 0.18, 
CPAQ-total,  F (1.8, 30.7) = 7.53,  p , 0.05, ηp
2 = 0.31, CPAQ-
pain willingness, F (2.0, 34.0) = 3.46, p , 0.05, ηp
2 = 0.17, 
CPAQ-activity engagement, F (2.0, 34.0) = 9.04, p , 0.05, 
ηp
2 = 0.35, MPQ-SF2-continous pain, F (2.0, 36.0) = 3.84, 
p , 0.05, ηp
2 = 0.18, FFMQ-total, F (1.4, 25.7) = 5.45, p , 0.05, 
ηp
2 = 0.23, FFMQ-describing, F (1.7, 30.5) = 4.02,  p , 0.05, 
ηp
2 = 0.18, and FFMQ-non-reactivity, F (1.4, 24.3) = 6.15, 
p , 0.05, ηp
2 = 0.26. LSD comparisons revealed significant 
improvement (p , 0.05) between T1 and T2 for FFMQ-total, 
FFMQ-non-reactivity, CPAQ-total, CPAQ-activity engage-
ment, and MPQ-SF-2-continuous pain, between T1 and T3 
for PCS-total, PCS-helplessness, FFMQ-total, FFMQ- 
describing, FFMQ-non-reactivity, CPAQ-total, CPAQ-activity 
engagement, MPQ-SF-2-continuous pain, and between T2 
and T3 FFMQ-describing, CPAQ-total, and CPAQ-pain 
willingness.
Mediation analysis revealed that scores on the FFMQ at 
T2 partially, but significantly, mediated the relationship 
between scores on the PCS at T1 and T3. Mid-intervention 
mindfulness scores were significantly related to end-of-
treatment pain catastrophizing scores (F (1.0, 17.0) = 33.9, 
p = 0.000; r = 0.82) and the relationship between PCS at T1 
and T3 (F (1.0, 17.0) = 35.1, p = 0.000; r = 0.82) was reduced 
(by r2 = 0.35) after controlling for FFMQ at T2 (F change 
(1.0, 16.0) = 7.4, p = 0.02; partial r = 0.56). Furthermore, 
both the Sobel test (Sobel value = 0.40, SEM = 0.18; z = 2.22, 
p = 0.03, CI.95 = 0.05, 0.75) and the bootstrapping analysis 
(Mean = 0.38, SEM = 0.17; CI.95 = 0.02, 0.74) showed that 
the total effect of PCS scores at baseline on PCS scores at 
the end of the intervention was significantly reduced once Journal of Pain Research 2011:4
Table 3 Mean (sD) values for pain, psychological and mindfulness variables across time (n = 19)
Measure Pre-intervention
(T1)
Mid-intervention
(T2)
Post-intervention
(T3)
Significance
(p value)
nRs-i 5.21 (2.80) 4.68 (3.00) 4.68 (2.75) ns
nRs-U 5.33 (2.89) 4.50 (3.37) 4.67 (2.63) ns
sLAP 11.89 (5.50) 12.39 (5.27) 12.83 (5.140) ns
FFMQ-totala,b 120.21 (21.80) 126.47 (22.53) 130.63 (20.82) 0.02
FFMQ-observing 29.32 (4.77) 29.61 (4.75) 30.89 (4.22) ns
FFMQ-describingb,c 23.58 (7.02) 23.87 (7.87) 25.84 (7.31) 0.03
FFMQ-acting with awareness 18.13 (5.04) 19.26 (4.91) 20.08 (4.80) ns
FFMQ-non-judging 23.84 (5.52) 25.55 (5.01) 25.37 (5.51) ns
FFMQ-non-reactivitya,b 19.16 (5.48) 21.53 (4.59) 22.00 (4.61) 0.01
PDi 38.14 (17.17) 36.83 (16.31) 33.81 (14.43) ns
PCs-totalb 25.33 (14.77) 21.67 (16.26) 20.40 (17.01) 0.04
PCs-helplessnessb 11.50 (7.43) 9.72 (7.47) 9.28 (7.83) 0.04
PCS-magnification 5.94 (3.45) 4.81 (3.51) 4.69 (3.18) ns
PCs-rumination 8.67 (4.83) 7.67 (5.72) 7.44 (5.89) ns
CPAQ-totala,b,c 60.47 (23.43) 65.44 (19.20) 69.50 (22.93) 0.003
CPAQ-activity engagementa,b 37.86 (15.13) 43.83 (11.58) 44.75 (14.57) 0.001
CPAQ-pain willingnessc 22.61 (10.35) 21.61 (9.53) 24.75 (10.72) 0.04
MPQ-SF-2-total 4.03 (1.86) 3.38 (1.73) 3.62 (2.14) ns
MPQ-SF-2-continuous paina,b 5.18 (1.72) 4.44 (2.03) 4.43 (2.14) 0.03
MPQ-SF-2-intermittent pain 3.32 (2.18) 2.57 (2.02) 3.40 (2.45) ns
MPQ-SF-2-neuropathic pain 3.51 (2.10) 3.20 (1.85) 3.01 (2.25) ns
MPQ-SF-2-affective pain 4.26 (2.45) 3.38 (2.49) 3.64 (2.72) ns
hADs-A 10.83 (4.40) 11.50 (5.06) 9.78 (4.47) ns
hADs-D 9.00 (4.54) 8.65 (4.65) 7.47 (4.26) ns
Note: Huynh–Feldt adjusted F-tests for significant main effects of time were conducted for all self-reported measures. Numeric rating scale for pain intensity: NRS-I; numeric 
rating scale for unpleasantness: NRS-U; Sum of Local Areas of Pain: SLAP; Five Facet Mindfulness Questionnaire: FFMQ; Pain Disability Index: PDI, Pain Catastrophizing Scale: 
PCS, Chronic Pain Acceptance Questionnaire: CPAQ; McGill Pain Questionnaire short form 2: MPQ-SF-20; Hospital Anxiety and Depression-Depression Scale: HADS-D, 
hospital Anxiety and Depression scale-Anxiety: hADs-A. ap , 0.05 for T1 vs T2; bp , 0.05 for T1 vs T3; and cp , 0.05 for T2 vs T3.
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Figure  3  Pre-  and  post-intervention  means  for  salivary  cortisol  levels  (µg/dL), 
averaged  across  the  two  sampling  days.  S1,  S2,  S3  indicate  first  sample  upon 
wakening, second sample 30 minutes after awakening, and third sample before sleep, 
respectively. Two outliers from the raw data that had z-scores of greater than   
±3 were adjusted to values that were ±2 standard deviations from the mean of that 
measurement.
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the mediator (ie, FFMQ scores at mid-intervention) was 
added to the model.
Cortisol analysis
As expected, reliability analysis performed on a randomly 
selected 10% of the cortisol samples showed very high 
between-sample correlations and did not show a significant 
difference between samples (t(22) = 1.98, p , 0.05, r = 0.98). 
Three cortisol samples were missing and were replaced with 
the value associated with the equivalent time point on the 
adjacent day of sampling. One participant underwent a medical 
procedure requiring her to fast before one of the days of sam-
pling, and so data collected for that day were not used. 
  Figure 3 shows pre- and post-yoga intervention mean salivary 
cortisol levels for S1, S2, and S3 averaged across the two 
sampling days.
The distributions of six of the 12 sampling time points 
(M1, M2, and M3 for the two days pre- and post-intervention) 
were skewed and five of the 12 sampling time points were 
non-normal according to the Shapiro–Wilk test (p , 0.05). 
  Consequently the cortisol data were analyzed by non- 
parametric Wilcoxon signed-rank tests.
Using a protocol-compliant analysis based on data from 
the 19 participants who completed the study, post-intervention 
cortisol AUC (median = 230.20) was greater than pre- 
intervention cortisol AUC (median = 189.46), z = −1.77, Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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p = 0.08 but this did not reach the conventional p , 0.05 level 
of significance. In contrast, using an intention-to-treat analysis 
based on the total sample (n = 22), in which the missing post-
intervention data for the three participants who dropped out 
of the study were estimated using the series mean, post-inter-
vention AUC (median = 263.69) was significantly greater than 
pre-intervention AUC (median = 189.46), z = −2.45, 
p , 0.05.
Median pre-intervention CAR (0.15 µg/dL) and diurnal 
change (0.18 µg/dL) did not differ significantly from the 
median post-intervention CAR (0.14 µg/dL) or diurnal change 
(0.18 µg/dL), z = −0.20 and z = −0.77, p . 0.05, 
respectively.
self-report diaries and adherence
Self-reported adherence to saliva sampling was 99.6%. 
In accordance with instructions, no participants reported 
engaging in physical exercise or consumed any alcohol, 
  caffeinated beverages, or food in the hour prior to taking S3 
on each of the four days of collection, as recorded in the 
cortisol diaries.
Discussion
This pilot study evaluated the effects of an eight-week yoga 
intervention on a variety of symptoms in a sample of women 
with FM. The results demonstrated post-intervention improve-
ment on a variety of pain and psychological variables, includ-
ing continuous pain, pain catastrophizing, pain helplessness, 
chronic pain acceptance, activity engagement, pain willing-
ness, mindfulness, non-reactivity to inner experience and 
ability to describe inner experience. Moreover, using an inten-
tion to treat analysis, total cortisol output increased signifi-
cantly post-intervention. These results suggest that a Hatha 
yoga program specifically tailored to the needs of a female 
FM population reduces continuous pain, pain catastrophizing 
and increases chronic pain acceptance and mindfulness.
Improvements in pain, pain catastrophizing and chronic 
pain acceptance are consistent with the results of a recently 
published Yoga as Awareness intervention for women with 
FM, which showed a reduction in pain, fatigue, pain cata-
strophizing, and an increase in acceptance, mood and 
  coping.26 The present results confirm many of these recent 
findings and extend them by suggesting that the pre- to post-
intervention changes we observed in mindfulness and cortisol 
levels may point to potential mechanisms of the present yoga 
program for women with FM.
The therapeutic benefits of mindfulness have been attrib-
uted to three components: intention, attention and attitude.59 
These components serve to generate awareness and purpose 
for certain behaviors, to facilitate observation of both internal 
and external experiences while withholding judgment about 
the nature of those experiences, and to enhance the quality of 
how one attends. Kindness, openness and acceptance are 
pivotal to cultivating a state of non-striving, in which one can 
let go of hoping for pleasant experiences. Shapiro et al posit 
that these three elements contribute to a large proportion of 
the variance in the transformations that result from mindful-
ness practice in terms of psychological functioning, pain, and 
other outcomes.59 These considerations are supported by the 
results of the mediation analysis showing that mid-  intervention 
levels of mindfulness (which increased significantly 
from baseline to T2 as shown in Table 3) mediated 
the reduction in pain catastrophizing from pre- to 
post- intervention. The results of the mediation analysis 
  support recent fear-avoidance models of chronic pain, which 
propose that chronic pain is in part maintained by fear of pain 
and pain catastrophizing through the negatively reinforcing 
effects of avoiding (eg, behavioral, emotional, interoceptive) 
pain-related cues and sensations.60 We suggest that the in-class 
emphasis that mindfulness practices placed on attending, 
without judgment, to pain and the ensuing cognitive-  emotional 
reactions (eg, catastrophic thoughts), permitted participants 
to circumvent their typical avoidance strategies and to experi-
ence the pain and distress, thereby reducing catastrophic 
appraisals by a process of interoceptive exposure.   Furthermore, 
it is possible that the mindfulness practices and their effects 
on reducing pain catastrophizing may have contributed to the 
significant increases in chronic pain acceptance observed over 
the course of the intervention, but further research is needed 
to better understand these relationships.
Given that HPA axis dysregulation in FM has received 
considerable attention, the present results showing increased 
levels of total cortisol output (AUC) is especially 
  noteworthy. This change suggests that the yoga program 
may have contributed to normalizing one aspect of HPA 
axis dysregulation observed in women with FM. The results 
are consistent with the findings from (1) an uncontrolled, 
multi-disciplinary CBT and aquatic exercise program for 
women with FM that showed a greater AUC for cortisol 
post-treatment,61 and (2) a non-randomized, but controlled, 
ten-week yoga program for women with rheumatoid arthri-
tis that showed no change in the CAR post-treatment.38 The 
absence of a significant change in the CAR in the present 
study fits with the non-significant change in post- 
intervention HADS depression scores in that an attenuated 
rise in the CAR has been related to greater subclinical Journal of Pain Research 2011:4 submit your manuscript | www.dovepress.com
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depressive symptoms and a greater rise to milder   symptoms.62 
However, it is possible that a more sensitive measure of the 
CAR and/or a longer yoga intervention may be required to 
demonstrate improvements in the CAR and HADS depres-
sion scores.
In order to evaluate diurnal variability, we sampled cortisol 
three times daily precluding a more precise analysis,63 which 
requires a more intense sampling protocol of 5–7 samples over 
the course of the day, for two consecutive days. It is possible 
that with a greater number of measurements, differences in 
diurnal variability may have been observed. It is also possible 
that the absence of a significant difference from pre- to post-
intervention AUC, when using the protocol-compliant analy-
sis, was due to a lack of power as significance was observed 
with the addition of the three participant’s missing data. A 
methodology employing a greater number of sampling time 
points would also allow for the division of participants into 
HPA subgroups of typical, flat or inconsistent.42 Since FM is 
associated with variable HPA functioning as well as a high 
variability of illness profiles,3 such grouping would be very 
useful in determining a more accurate picture of HPA patterns 
in this population. Further grouping  according to symptom 
subgroups may be most effective when evaluating the effects 
of a pain   management program,64 and future research might 
consider the use of a larger sample size to allow for classifica-
tion of FM participants according to sensory symptoms and 
comorbidities65 within the context of a yoga intervention. 
Future research should measure other variables that are impli-
cated in HPA function, such as growth hormone or inflamma-
tory cytokines, to better understand how a yoga intervention 
might impact HPA function more broadly. Taken together, it 
is clear that randomized, controlled trials are needed to further 
examine the effect of mind-body practices, such as yoga, on 
cortisol in women with FM.
Speculation on the underlying mechanisms of yoga for 
chronic pain conditions includes physiological changes that 
impact the pain experience.25 Yoga promotes the relaxation 
response, which consists of a decreased heart rate, increased 
breath volume, and increased digestive function, amongst 
improvements on other physiological responses to stress, by 
increasing parasympathetic nervous system activity and 
decreasing sympathetic nervous system activity.66 Recent 
research indicates that advanced yoga practitioners have 
lower interleukin-6 levels than novice practitioners and it 
has been suggested that a regular yoga practice may serve to 
inhibit a pro-inflammatory response to stress.67 It is possible 
that such physiological changes may also have contributed 
to the post-yoga intervention changes we observed. Future 
research should examine the effects of yoga on these 
  psycho-immune-endocrine interactions in FM.
The present yoga intervention did not result in improve-
ments in the HADS depression and anxiety scores over the 
course of the yoga program. These findings are not con-
sistent with other yoga studies of women with FM26 and 
rheumatoid arthritis.38 Reasons for this discrepancy include 
differences among the studies in the measures used to 
assess depressive symptomology (ie, Beck Depression 
Inventory,38 Revised Fibromyalgia Impact Questionnaire,26 
HADS in the present study), the duration and intensity of 
the yoga program (10 weeks,38 8 weeks plus group 
discussion,26 8 weeks), or both. A longer intervention, 
including a social support component, may be needed to 
produce post-intervention improvements in depression as 
measured by the HADS.
There are limitations to the present study. The main 
methodological shortcoming is the absence of a control 
group, raising the possibility that the observed effects are 
not due to the yoga program per se but reflect spontaneous 
recovery, regression to the mean, and/or non-specific factors 
such as a caring atmosphere and attention paid to participants. 
In addition, the relatively small sample size limits statistical 
power and the absence of males limits the generalizability 
of the findings. Finally, notwithstanding the observed post-
intervention changes in total cortisol and diurnal variability, 
the absence of a change in the CAR may be a limitation of 
our salivary cortisol sampling procedure. More frequent 
sampling of salivary cortisol would also permit a more fine-
grained classification of HPA axis functioning.
In conclusion, the results of the present pilot study suggest 
that an eight-week yoga program helps to improve various 
psychological and pain related variables; namely, to decrease 
continuous pain and pain catastrophizing, to increase chronic 
pain acceptance and levels of mindfulness, as well as to alter 
cortisol levels in women with FM. Use of a randomized, con-
trolled design with a larger sample size is recommended to 
better understand the effects of a yoga intervention on the above 
variables. A longer intervention may yield more robust findings, 
and a six-month follow-up may provide valuable information 
concerning the potential for lasting improvement.
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